Approval · Notice of Compliance 19158 · 2017
POLYFLEX: Notice of Compliance 19158
Issued April 13, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19158
- Date
- April 13, 2017
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| POLYFLEX | 00849405 | Marketed |
Medicinal ingredients
- AMPICILLIN TRIHYDRATE 25 G per VIAL